PATENT CLAIM ANALYSIS

Application Number: 16118001
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "356000"]

Abstract:
Disclosed herein are methods of treating disease with a combination of a RXR agonist and a thyroid hormone.

Claim (Index 26):
The method according to  claim 1 , wherein the neurotrophic factor is administered subcutaneously or intramuscularly.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 96.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15339762', '15812821', '15339752', '14507730', '15988965']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8902205620317826
- 35 USC 102 Novelty (BERT): 0.6136907858084705
- Combined Prediction Score: 0.8625675844094514
- Mean Citation Score: 611.4666759999999
- Max Citation Score: 747.0627
- Similarity Product: 480.5075969037115

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test